Working memory and response inhibition in patients with bipolar I disorder during euthymic period by Farahmand, Z. et al.
Iran J Psychiatry Behav Sci. 2015 March; 9(1):e209. DOI: 10.17795/ijpbs209
Published online 2015 February 2. Original Article
Working Memory and Response Inhibition in Patients With Bipolar I Disorder 
During Euthymic Period 
Zahra Farahmand 
1
; Mehdi Tehrani-Doost 
2,*
; Homayoun Amini 
2
; Abolfazl Mohammadi 
1
; 
Mosleh Mirzaei 
3
; Azar Mohamadzadeh 
2
1Department of Clinical Psychology, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
2Department of Psychiatry, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
3Mental Health Research Centre, Tehran Psychiatric Institute, Faculty of Behavioral Science and Mental Health, Iran University of Medical Sciences, Tehran, IR Iran*Corresponding author: Mehdi Tehrani-Doost, Department of Psychiatry, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, IR Iran. Tel: +98-2155412222, 
E-mail: tehranid@sina.tums.ac.ir
Received: July 25, 2014; Revised: December 5, 21014; Accepted: January 20, 2015
Background: Several cognitive domains, including attention, memory, and executive functions are impaired in bipolar disorder.
Objectives: This study aimed to investigate two executive functions (working memory and response inhibition) in patients with bipolar I 
disorder during remission of the symptoms.
Patients and Methods: In this case-control design, 30 bipolar I patients (18 to 45 years old) were matched with 30 ones in the control 
group in terms of age, gender, and education. The patients were selected from Roozbeh Psychiatric Hospital (a hospital affiliated to Tehran 
University of Medical Sciences) from May to October 2013. They were evaluated and contrasted using working memory (Spatial Span and 
Spatial Working Memory (SSP and SWM)) and response inhibition (Stop Signal Task (SST)) tests.
Results: We used independent t-tests for comparing and contrasting 2 groups on total and sub-scales scores of these 3 tests. In terms 
of SWM test there was a significant difference in between-group error between the two groups (P = 0.05); there was also a meaningful 
difference between the strategies used by two groups (P = 0.05). In SSP test, a significant difference appeared between averages of span 
length of the two groups. In the first and last item delays, there was also a clear difference, but the total error index was not noticeably 
different. In SST test, the direction error indicator in start-stop trials indicated a major difference, while in successful stops ratio, the case 
group had a lower ratio. In addition, reaction time to stop signs in bipolar group was meaningfully lower than the control group.
Conclusion: In conclusion, even during remission phase, executive dysfunction is detectable at least in some areas in patients with 
bipolar disorder.
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1. Background
Bipolar disorder is characterized by fluctuation and re-
lapses of mania and depression periods. This pathologic 
mood definitely impacts on cognitive functions. Several 
cognitive domains, including attention, memory, and ex-
ecutive functions are impaired in bipolar disorder (1, 2). 
Meanwhile, in recent decades, there has been an increas-
ing tendency to study neurocognitive deficits like execu-
tive functions among researches (3). Executive functions 
are a series of problem-solving tasks to achieve specific 
goals (4), including abilities like attention, reasoning, 
planning, working memory, response inhibition, and 
interfering factors’ control. These functions are vital for 
human complex behavior. Disruption in these functions 
of often ten causes psychiatric or behavioral disorders, 
suggesting their important role in human complex 
behavior (5). Executive functions are hypothesized in 
explanation of many disorders such as schizophrenia 
(6), obsessive-compulsive disorder (7), autistic disorder 
(8), eating disorders (9), panic disorder (10), and post-
traumatic stress disorder (11). Bipolar disorder is among 
these disorders (12). 
In fact, quite enough studies have repeatedly shown 
that bipolar patients suffer from cognitive impairments 
both during acute phases (13) and remission/euthymic 
periods (14, 15). Meta-analysis of Robinson et al. (12) on 26 
studies (689 patients and 721 controls), suggested that as-
pects of executive function had a large effect size ([d ≥ 
0.8] indicating marked impairment), whereas other cog-
nitive domains, including response inhibition and set 
shifting had medium effect (0.5 ≤ d ≤ 0.8), and finally 
verbal fluency, immediate memory, and sustained atten-
tion had small effect sizes (0.2 ≤ d ≤ 0.5). An updated 
meta-analysis of Robinson et al. (12), which added stud-
ies on first-degree relatives provided the same results on 
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cognitive impairments for euthymic patients and to less-
er degrees, but still significantly different from healthy 
controls, for first-degree relatives (16). 
Because cognitive impairment appears to occur in the 
early stages of bipolar disorder and increases both dur-
ing depressive episodes and after periods of mania, some 
researches consider this defect as a state marker (17, 18). 
Other studies have shown that cognitive deficits exist 
both after a long symptom-free and controlled subthresh-
old symptoms (12). A recent research with a considerable 
follow-up period has also spotted that cognitive deficits 
are stable features in bipolar patients with normal mood 
during the next 6 years (19).
Among cognitive deficits in bipolar disorder, response in-
hibition impairment accompanies manic symptoms (e.g. 
impulsivity, psychomotor agitation, over-talkativeness, 
overspending, and risky sexual behavior). Some research-
ers suggest that impulsivity, which includes some defects 
in response inhibition, is higher in patients with bipolar 
disorder even during normal mood periods (20, 21). 
The importance of cognitive deficits in euthymic pa-
tients has many aspects. Cognitive impairments have 
adverse impacts on functions such as daily activities, job, 
interpersonal relationships, and quality of life (22); also 
they have significant correlation with weak psychosocial 
functioning in the future (19). On the other hand, due to 
negative psychosocial consequences of cognitive deficits 
on both patients' medication compliance (13) and psycho-
logical interventions complementing pharmaceutical 
treatment (23), identification and rehabilitation of these 
defects stress their particular importance. In other words, 
empowerment of bipolar patients, in terms of psychoso-
cial aspects, has been a major concern for clinicians. 
Studies like this can provide mental health practitio-
ners with useful intervention strategies, because inves-
tigators soon found that effectiveness of psychosocial 
interventions in these patients is bound to considering 
their cognitive limitations (24). As a new approach in last 
few years, it aims to help these patients by intervening 
on their basic cognitive components, called neuropsy-
chological remediation or cognitive rehabilitation (25). 
By manipulation of basic cognitive processes, these in-
terventions are supposed to improve cognitive functions 
and consequently promote psychosocial functioning of 
bipolar patients (26). 
It seems that despite convincing evidence on cognitive 
impairments during euthymic periods, more researches 
are still needed with methodologically solid designs to 
control confounding factors such as medication, and sub-
symptoms effects (12); and applying measures with high 
sensitivity and specificity for evaluating cognitive ele-
ments of bipolar patients (16); as well as using a well-de-
signed battery for assessing cognitive impairments (27).
2. Objectives
This study aimed to evaluate two executive functions 
(working memory and response inhibition) in euthy-
mic bipolar patients and comparing them to the control 
group. Our hypothesis is that working memory and re-
sponse inhibition in euthymic patients are weaker com-
pared to healthy controls. 
3. Patients and Methods
In this case-control study, 30 patients (18 to 45 years) 
with bipolar diagnosis admitted to Roozbeh Psychiatric 
Hospital (from May to October 2013) entered the study 
and were compared to 30 healthy controls. In patients 
group, 25 were manic in which 17 ones had psychotic 
features; the other 5 patients had mixed episodes. The 
patients were examined within 3 to 4 weeks after symp-
toms remission (in euthymic period). After psychiatric 
evaluation and determining their diagnosis, and obtain-
ing their primary consent, the patients were referred to 
a researcher. Then the researcher described the study to 
them and if they wanted to participate in the study, they 
would be asked to complete a consent form. After that, 
they were interviewed using Structured Clinical Inter-
view for DSM-IV for Axis (SCID-I) disorders. The interviews 
were carried out by a clinical psychologist.
Inclusion criteria included age between 18-45 years, diag-
nosis of bipolar disorder based on psychiatrist diagnosis, 
and SCID-I diagnoses. Exclusion criteria consisted of any 
obvious cognitive disorders, major depressive episode, 
clinical anxiety, substance abuse, and mental retardation. 
Most of the patients were polymedicated. All 30 patients 
were receiving mood stabilizers; 22 of them were taking 
anxiolytics; and 17 took also anti-psychotic. None of the 
patients were getting electro convulsive therapy.
In addition, the control group was interviewed using 
SCID-I as a diagnostic tool for ruling out psychiatric disor-
ders; and if they met the criteria for any axis I disorders or 
a history of these disorders, they were excluded. The con-
trol group subjects were selected among hospital staff 
and other available healthy people. They were assessed 
based on inclusion and exclusion criteria. Participants 
also matched with the patient group based on age, gen-
der, and degree of education. 
3.1. Measures
To assess executive functions (working memory and 
response inhibition), Cambridge Neuropsychological 
Test Automated Battery (CANTAB) was applied, which was 
originally developed at Cambridge University in 1980s 
(28) and now provided by Cambridge Cognition (www.
cambridgecognition.com). It is a computer-based cogni-
tive assessment system consisting of 22 neuropsychologi-
cal tests for various cognitive functions. These tests are 
administered to subjects using a touch screen computer 
with no specific language or culture bound, it is based 
on the standard cognitive tests that are routinely used 
in psychological assessment (29). Since the tests have no 
use in diagnosis or determining disorder and are based 
on comparison with no need to the mean score like other 
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neuropsychological tests, they can be applied without 
confirming their reliability and validity to reflect be-
tween–group differences. These test kits are validated in 
a sample of 3000 people. In this study, to assess working 
memory, SWM, SSP, were used and response inhibition 
was obtained through SST test.
3.2. Spatial Working Memory 
This test is a form of self-ordered searching task. It as-
sesses the ability to retain spatial information and ma-
nipulate remembered items in working memory, while 
the subject performs the task to achieve goals. The test 
consists of a series of colored squares (boxes) that are 
displayed on the screen. According to the guidelines, by 
touching boxes and using a process of elimination, the 
subject should find one hidden blue ‘token’ in each of 
boxes and use them to fill up an empty column on the 
right hand side of the screen. Each box has only one hid-
den blue sign. When it is found, the box no longer pro-
vides another sign. Thus it seems that in the next item, 
searches should be limited to boxes that contain blue 
signs. This process goes on until all blue signs of the box-
es are discovered on the screen. When the trial ends up, 
a new one begins (with new color and position different 
from previous trials). This test consists of 4 experimental 
trials and every trial has 3 boxes for search (the first 4 tri-
als will not be scored), then test continues with 4, 6, and 8 
boxes. The variables used in SWM test include errors (be-
tween-group, within-group, and double errors), strategy, 
and latency (time from when the task is presented until 
the participant’s first touch for opening the box) (27).
In this test, when a subject touches a box that blue signs 
have already been found in, errors (between-group) are 
recorded. Within-group errors include the number of 
errors occurring within a search, for example, the fre-
quency of selecting a box that had been found empty in 
previous searches, (frequency of re-selection the empty 
box in a trial). Double errors are calculated when the par-
ticipant makes an error (re-selection of an empty box) 
that can simultaneously fall within group error catego-
ries. Owen et al. (30) have proposed an effective strategy 
for accomplishing this task. To start, a predetermined 
sequence of boxes marked with a blue sign were found 
to start and when it comes back, the new scouring is to 
begin. Estimated use of this strategy (strategic points) 
is obtained from the total number of times that partici-
pants seek a new one with 6 and 8 boxes. The high score 
indicates a poor use of these strategies and a low score 
indicates an efficient use.
3.3. Spatial Span 
Spatial span assesses working memory capacity, which 
is a visuospatial analogue of the digit span test. This test 
measures the ability to remember the location and order 
of a set of visual stimuli (white squares) displayed on the 
screen. The number of boxes is increased from 2 at the 
start of the test to 9 at the end, and sequence and color are 
changing through the test. Each stage includes 3 tentative 
efforts. The test is stopped when the participant fails in all 
3 trials of a stage. Time span is defined as the highest level 
that the subject can remember in a trial. This measure-
ment requires both visual and spatial components repre-
senting the ability to store data temporarily or online in 
order to plan more operations in the future. This test has 
5 variables span length, mean time to first response (span 
length 2), mean time to last response (span length 2), total 
errors, and total usage errors (30, 31).
3.4. Stop Signal Task
This test measures the response inhibition ability. In 
each experimental trial, the participant should press the 
arrow that displayed on the screen (according to the ar-
row’s left or right direction, the subject should press the 
corresponding button). If an auditory tone is presented, 
the participant must inhibit that response. This test con-
sists of two sections: In the first one, the participant is 
introduced to press the left hand button when he sees 
a left-pointing arrow, and right hand button when see-
ing a right-pointing arrow. There is one block of 16 trials 
for the subject to practice this. In the second section, the 
participant is told to continue pressing buttons when 
they see the arrows, as before, but, if they hear an audi-
tory signal (a beep), they should withhold their response 
and not press the button. This part consists of 4 blocks 
each containing 16 trials (total trials: 64). The variables 
of SST include 5 items including direction errors on stop 
and go trials, proportion of successful stops, median cor-
rect reaction time on go trials, stop signal delay, and stop 
signal RT (31).
3.5. Young Mania Rating Scale 
This scale was developed by Young, Biggs, Ziegler, and 
Meyer (32) for mania evaluation. This measure rates 
symptoms of bipolar disorder in mania episode and con-
sists of 9 items. The scoring scale is based on severity of 
symptoms (total score: 60). There was a high correlation 
between scores of two independent clinicians on both the 
total score (0.93) and the individual item scores (0.66 to 
0.92) (32). Reliability and validity of this scale were accept-
able in an Iranian sample (Isfahan province) (33). In this 
study, concordant validity of YMRS with the World Health 
Organization World Mental Health Composite Interna-
tional Diagnostic Interview (WHO WMH-CIDI) was 0.87. 
Discriminatory analysis results indicated 17.14 and the op-
timal cut-off point with 98.4% sensitivity and 98.4% speci-
ficity. YMRS (Young Mania Rating Scale) is a valid instru-
ment with acceptable sensitivity and specificity which 
can be applied in both clinical and research settings.
3.6. Beck Depression Inventory-II
This scale was first applied by Beck in 1961 and then 
revised in 1971. It is a 21 multiple-choice test with 0 to 3 
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scored items. Its test-retest reliability has been reported 
between 0.48 to 0.86 and a mean of 0.86 (34). Internal 
consistency of BDI-II was estimated to be 0.73-0.93 and 
the correlation between parallel forms was 0.89. Concur-
rent validity of the questionnaire with the Hamilton Rat-
ing Scale for Depression (HRSD) and depression subscale 
of SCL-90 has been 0.71 and 0.89, respectively (34). In a 
study by Ghassemzadeh et al. (35) on a Persian version of 
BDI-II, the test had high internal consistency (Cronbach α 
= 0.87) and acceptable test-retest reliability (r = 0.74).
3.7. Beck Anxiety Inventory 
This questionnaire consists of 21 multiple choice items 
(scoring from 0 to 3), which assesses the severity of anxi-
ety. The total score ranges from 0 to 63. This question-
naire focuses mainly on physiological aspects of the 
anxiety. Three items relate to anxious mood, 3 ones assess 
specific phobias and other questions evaluate autono-
mous hyperactivity symptoms and tension. Beck et al. 
(36) have reported the internal consistency of this scale 
as 0.93 and its test-retest reliability as 0.75. This question-
naire was validated in Iran by Kaviani and Mousavi (37). In 
their study, internal consistency measured by Cronbach 
α was 0.92; test-retest reliability was 0.83 and within class 
validity was 0.83.
SPSS-19 was used to analyze the data. Independent t-test 
was applied to assess differences between means consid-
ering P < 0.05 significant level. Descriptive statistics were 
applied for the demographic variables.
4. Results
In this study, 30 patients (15 females, 15 males) and 30 
healthy controls (15 females, 15 males), were evaluated. 
The two groups were matched up to age (mean ± SD of 
patients, 32.6 ±7.85 years; the control group 32.43 ± 7.64 
years) and had no significant differences. There were 
no significant differences between the two groups in 
terms of degree of education (P < 0.05, df = 58, t = -0.294) 
(number of patients in primary-secondary school level 
were 7 (23.3%), and in control group was 5 (16.7%); in the 
second category, high school/diploma level, there were 
12 patients (40%), and 15 controls (50%); in diploma/BA 
level, 9 patients (30%), and 7 controls (23.3%), and in the 
last category, postgraduates (MA and Ph.D.), there were 2 
people (6.7%) for patients group, and 3 ones for control 
group (10%)). Participants’ scores regarding BAI were not 
significantly different (P ˂ 0.05, df = 58, t = -0.202). There 
were also no significant differences in BDI-II scores (P > 
0.05, df = 58, t = 2.84), and the mean score on YMRS was 7 
in patients groups.
 Table 1 presents the results of the SST test. Regarding 
direct errors on stop and go trails, bipolar group scored 
significantly higher than controls (P ˂ 0.05, t = 3.08) and 
the proportion of successful stops in the bipolar group 
was significantly lower than the control group (P ˂ 0.05, 
t = -2.02). Stop signal reaction time in bipolar group was 
significantly greater than the control group (P ˂ 0.05, t = 
4.14). Median correct reaction time on go trails was not 
significant between the two groups (P ˂ 0.05, t = 1.16). The 
delay between the two groups was not significant on stop 
signal delay (P ˂ 0.05, t = -1.13).
 Table 2 presents SSP results. With regard to span length, 
bipolar group got lower scores than the non-clinical 
group, and this difference was significant (P ˂ 0.05, t = 
-3.89). The mean latency to first response in the bipolar 
group was higher than the control group, and the dif-
ference was significant (P ˂ 0.05, t = 3.40) and the mean 
response latency in the last item was also significantly 
greater in bipolar group (P ˂ 0.05, t = 3.88). As shown in 
Table 2, the mean of total errors in bipolar group is high-
er than the control group, but this difference was not sig-
nificant (P > 0.05, t = -1.14) and the total usage errors was 
similar between the two groups (P ˂ 0.05, t = 0.291).
Table 1. Comparison of Patients and Control Group in Response Inhibition variables
Variables Mean ± SD df T P Value
Direct errors on stop and go trails 58 3.08 0.003 a
Patient, n = 30 9.23 ± 15.54
Control, n = 30 0.4667 ± 0.7760
Proportion of successful stop 58 -2.02 0.048 a
Patient, n = 30 0.5093 ± 0.1559
Control, n = 30 0.6097 ± 0.2223
Median correct reaction time on 
go trails
57 1.16 0.247
Patient, n = 30 914.95 ± 287.59
Control, n = 29 823.67 ± 311.88
Stop signal delay 57 -1.13 0.259
Patient, n = 30 546.72 ± 163.25
Control, n = 29 607.01 ± 237.61
Stop signal reaction time 57 0.14 0.001 a
Patient, n = 30 368.22 ± 163.65
Control, n = 29 216.65 ± 111.75
a P ˂ 0.05.
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Table 3 shows the test results of SWM. The total num-
ber of between-errors was significantly higher in bipolar 
group (P ˂  0.05, t = 3.98). Between-group errors in 4, 6, and 
8 boxes stages were significantly higher in bipolar group 
compared to the control group (P ˂ 0.05, t = 2.25; P ˂ 0.05, 
t = 3.30; and P ˂  0.05, t = 3.76, respectively). Strategies used 
in clinical and non-clinical groups were significantly dif-
ferent (P ˂ 0.05, t = 2.33). The total error was greater in 
bipolar group compared to the control group (P ˂ 0.05, 
t = 3.76). In 4 boxes step, there was no significant differ-
ence in total errors between the two groups (P > 0.05, t = 
1.91), but total errors in 6 and 8 boxes levels were higher in 
bipolar group compared to the control group (P ˂ 0.05, t 
= 3.24; P ˂ 0.05, t = 3.06, respectively). In double-error and 
within-group error variables the two groups were not sig-
nificantly different.
Table 2. Comparison of Patients and Control Group in Working Memory variables
Variables Mean ± SD df T P Vaue
Span length 58 -3.89 0.001 a
Patient, n = 30 4.90 ± 1.09
Control, n = 30 6.03 ± 1.15
Mean time to first response 58 3.40 0.01 a
Patient, n = 30 3606.25 ± 924.58
Control, n = 30 2992.36 ± 349.35
Mean time to last response 58 3.88 0.001 a
Patient, n = 30 4617.68 ± 1070.75
Control, n = 30 3810.53 ± 380.74
Total errors 58 -1.14 0.256
Patient, n = 30 12.47 ± 4.32
Control 14.07 ± 6.30
Total usage errors 58 0.291 0.772
Patient, n = 30 2.10 ± 1.42
Control, n = 30 2 ± 1.23
a P ˂ 0.05.
Table 3 . Comparison of Patients and Control Group in Working Memory Variables
Variables Mean ± SD df T P Value
Between errors 58 3.98 0.001 a
Patient, n = 30 53.37 ± 22.32
Control, n = 30 33.13 ± 16.64
Between errors 4 boxes 58 2.25 0.028 a
Patient, n = 30 2.37 ± 2.91
Control, n = 30 1 ± 1.57
Between errors 6 boxes 58 3.30 0.002 a
Patient, n = 30 17.27 ± 11.22
Control, n = 30 9.57 ± 6.07
Between errors 8 boxes 58 3.42 0.001 a
patient, n = 30 33.73 ± 13.25
Control 22.57 ± 11.97
Strategy 58 2.33 0.023a
Patient, n = 30 38.80 ± 4.74
Control 36.33 ± 3.33
Total errors 58 3.76 0.001 a
Patient 56.30 ± 23.49
Control 35.97 ± 18.01
Total errors 4 boxes 58 1.91 0.06
Patient, n = 30 3.13 ± 3.84
Control, n = 30 1.53 ± 2.46
Total errors 6 boxes 58 3.24 0.002 a
Patient, n = 30 18.20 ± 11.82
Control, n = 30 10.20 ± 6.50
Total errors 8 boxes 58 3.06 0.003 a
Patient, n = 30 34.97 ± 13.93
Control, n = 30 24.23 ± 13.16
a P ˂ 0.05.
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5. Discussion
In this study, the performance of working memory and 
response inhibition of bipolar patients were assessed 
during remission phase of mania symptoms. SST results 
showed that the direction errors in start-stop trials were 
higher in bipolar group; and in successful stop ratio, the 
patients were less successful than the controls. In addi-
tion, the stop reaction time of bipolar group was greater 
than the control group, indicating that people with bipo-
lar disorder have more errors in SST even after remission 
of acute mania symptoms. The results also showed that 
the time between moving and stopping, considered as re-
sponse inhibition reaction time (SSRT), was higher in pa-
tients than controls. In fact, it took more time for bipolar 
patients to inhibit their responses. These results are con-
sistent with the findings of a meta-analysis study done 
by Hajek (38). This meta-analysis included 30 studies, 
consisting of 635 patients and 677 controls. Findings of 
this study showed that the patients’ performance during 
periods of normal mood (228 patients and 277 controls) 
was different from healthy controls, also the accuracy 
level in bipolar group in doing GNG test, SSRT, and Stroop 
attention test was weaker than control group during pe-
riods of normal mood. There were similar deficiencies in 
not paying attention to Stroop interferes, and stop sig-
nal reaction time (SSRT) was significantly different from 
matched control group. The patient group had a lower 
precision and needed more time to inhibit responses. In 
this study, the involved brain areas were also examined 
by the functional magnetic resonance imaging (FMRI). 
Furthermore, the study of Gruber (39) compared 30 pa-
tients suffering from major depression, 17 patients with 
manic bipolar disorder, and 22 patients with depressive 
bipolar disorder by several neurocognitive tests (mem-
ory, attention, executive function, and SST). Evaluations 
were done at admission and 7 weeks after discharge (in 
recovery period). In the first evaluation, manic patients 
had lower performance in response inhibition reaction 
time (SST) compared to depressive bipolar patients (EF = 
0.75). Although all three groups showed significant im-
provement after the follow-up period, deficiency in some 
domains (especially executive function) remained con-
stant. Manic patients reported most errors among the 
three groups. In addition patients with mania had weak-
er results in inhibition of start responses than patients 
with major depression (EF = 0.87) and also had poorer 
performance compared to depressed bipolar patients (EF 
= 0.58). They also had slower reaction time than patients 
with bipolar depression at the start of the responses (EF 
= 0.55). Larson et al. (40) had findings similar to the pres-
ent study. In their study, two groups of bipolar patients 
(15 ones during manic episode, and 18 patients during 
normal mood period), were compared to 18 healthy con-
trols using Object Alternation Task. Patients during both 
periods of mania and normal mood showed greater er-
rors in response inhibition compared to the control 
group. Other researches (41, 42) have confirmed deficits 
in response inhibition during periods of normal mood 
in patients with bipolar disorder. There are few studies 
inconsistent with previous ones (43). In this study, 20 
patients with bipolar disorder during period of normal 
mood were compared to 20 controls in response inhibi-
tion test (GNG); they were also examined by FMRI during 
this test. Results showed that performance was similar in 
both groups, while the activity pattern of involved brain 
areas in response inhibition was different.
On the other hand, both the meta-analysis studies by 
Robinson et al. (12) that examined the patients during 
periods of normal mood and Bora (44) that examined 
the close relatives of bipolar patients, suggested that re-
sponse inhibition was the most prominent factor in the 
phenotype of bipolar disorder. This finding is supported 
by other researches; patients who are at risk of bipolar 
disorder show structural changes in areas associated with 
inhibition (38). In conclusion, it seems that enough evi-
dence supports the idea that response inhibition deficit is 
an independent phenomenon existing beyond pathologi-
cal mood episodes in patients with bipolar disorder.
The results of the second hypothesis, in SWM test, 
showed more within-group errors in bipolar patient. In 
the strategies employed index, there was also significant 
difference between the two groups, in other words, bi-
polar patients in normal mood period had more errors 
on SWM test. This finding regarding within-group error 
is consistent with Thompson et al. (45). In their research 
63 bipolar patients during normal mood period (27.3 
months on average) were compared to 63 healthy par-
ticipants. Results showed that patients had more within-
group errors compared to healthy group in SWM, but 
in strategies employed by the two groups there was not 
any significant difference, which contradicts with our 
finding regarding strategies. In addition, Sweeney et al. 
(46) using CANTAB, compared 58 patients with major de-
pression, 21 bipolar patients in depressive phase, 14 ones 
in mania or mixed episodes, to 51 normal individuals. 
SWM test results showed no significant differences be-
tween groups. Patients in mania or mixed episodes had 
lower performance compared to depressed patients and 
healthy controls. Also, in the employed strategies, there 
were significant differences between groups; patients in 
manic or mixed phase had the least stability compared to 
those in the control group or depressed patients.
The third part of our findings regarding SSP test indicat-
ed that the span length of clinical group was significantly 
lower compared to the healthy group. In fact, the clinical 
group could remember fewer items. A significant differ-
ence existed in the meantime to first response and mean-
time to last response delays between the two groups, so 
that patients needed more time to do their first and last 
touches. These are consistent with the results of Sweeney 
et al. (46) that bipolar patients in normal mood period had 
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significantly weaker performance in SSP test compared to 
the control group. Our findings in this section are also 
compatible with the findings of Dittmann et al. (15), who 
examined 65 patients with bipolar disorder type I, 38 pa-
tients with bipolar disorder type II (both during the peri-
od of normal mood), and 38 healthy controls using a brief 
neuropsychological battery. Results indicated that bipo-
lar patients had poorer performance in some items, such 
as working memory (measured by the Wechsler Memory 
Subscale) compared to the control group. There was no 
significant difference in cognitive functioning between 
the two groups. Finally, it was in agreement with other 
studies confirmed impaired cognitive functions during 
periods of normal mood in patients with bipolar disorder 
(23), such as Cavanagh's study (23), which assessed memo-
ry and verbal learning in patients with bipolar disorder in 
euthmic phase compared to normal group. Their results 
showed that patients demonstrated significantly poorer 
performance in immediate recall. In fact, they could re-
tain fewer items. Findings also revealed negative correla-
tion between frequency of mania episodes and memory 
function (delayed recognition domain). 
Our study has some limitations that make it difficult 
to generalize these findings. First of all, our sample is 
small. It would be useful to replicate this study with a 
large sample. The second limitation is the possible in-
terference of sub-symptoms in cognitive functioning of 
the patients and the third one is controlling the effect of 
medications. Most of our patients were on medications 
including mood stabilizers, antipsychotics, and anxiolyt-
ics. Early evidence relating positive effects of mood stabi-
lizers on neurocognitive functioning of bipolar patients 
(47) and at the same time some negative effects of anti-
psychotics on neuropsychological functioning in bipolar 
patients (48, 49) make it hard to draw conclusion about 
medication effects. We suggest that further researches 
with longitudinal designs and using homogenous pa-
tients based on their medication regimes can shed light 
on some of these limitations. We also suggest that future 
studies should do more with these confounding factors. 
In conclusion, current research suggests that bipolar pa-
tients had some inabilities in working memory ability 
and need more time to inhibit their responses compared 
to the control group. These findings have some clinical 
implications for practitioners such as paying more atten-
tion to cognitive symptoms that seems to be impaired 
even during remission. Also they would be better to con-
sider neuropsychological remediation in their bipolar 
patients’ treatment protocols. 
Future studies should answer other remaining ques-
tions such as what cognitive function in which type of bi-
polar disorder is stable or transient, and how much these 
stable cognitive dysfunctions take part in patients’ spe-
cific psychosocial areas of functioning. Also they should 
clearly respond to questions regarding severity of the 
illness, and specific clinical features like presence of psy-
chosis, substance abuse, and so on.
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